한글목차

유방 병변 국소화 세계 시장은 2024년에 7억 6,426만 달러로 평가되었습니다. 2030년까지 10억 7,378만 달러에 달할 것으로 예상되며, 예측 기간 동안 6.03%의 연평균 성장률(CAGR)을 보일 것으로 예측됩니다.

이 시장은 전 세계 유방암 발병률 증가와 정확한 진단 및 수술적 개입 방법에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다.

유방 병변 국소화 기술은 방사선과 의사와 외과 의사가 유방 보존 수술 및 생검 시 비정상 조직을 정확하게 식별하고 제거하는 데 중요한 역할을 합니다. 이러한 방법은 악성 또는 의심스러운 병변을 효과적으로 치료하는 동시에 건강한 조직을 보존하는 데 필수적입니다.

주요 성장 요인 중 하나는 유방암 조기 발견에 대한 인식이 높아지면서 검진 프로그램이 광범위하게 시행되고 있다는 점입니다. 유방암은 전 세계 여성들에게 가장 흔한 암 중 하나이기 때문에 조기 진단은 생존율과 치료 결과를 개선하는 데 필수적입니다. 따라서 수술의 정확도를 높이고, 재수술의 위험을 최소화하며, 전반적인 임상적 성공률을 향상시킬 수 있는 신뢰할 수 있는 첨단 국소 진단 기술의 개발이 강조되고 있습니다.

그러나 첨단 현지화 기술은 비용이 많이 들고 전문적인 교육이 필요하기 때문에 시장 확대에 걸림돌이 될 수 있습니다. 이러한 요인들은 특히 중저소득 국가에서 장벽이 되고 있습니다. 또한, 복잡한 규제와 지역별로 일관성 없는 상환 체계로 인해 특정 시장에서의 도입이 제한될 수 있습니다.

주요 시장 성장 촉진요인

세계 헬스케어 부문 확대

주요 시장 과제

신흥국 시장에서의 접근성 제한

주요 시장 동향

조기 발견과 기술 혁신의 중요성

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계 유방 병변 국소화 시장에 대한 COVID-19의 영향

제5장 세계의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(방사성 동위 원소 국재, 무선 유도에 의한 잠재 병변 위치 특정(ROLL), 방사성 핵종 위치 특정(RSL), 자기 트레이서, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 유방 병변 국소화 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 유방 병변 국소화 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Becton, Dickinson and Company
• SOMATEX Medical Technologies GmbH
• Argon Medical Devices, Inc.
• Merit Medical Systems, Inc.
• Cook Group Incorporated
• STERYLAB S.r.l.
• Theragenics Corporation
• Mdl Srl
• Stryker Corporation

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

Global breast lesion localization methods market was valued at USD 764.26 million in 2024 and is projected to reach USD 1,073.78 million by 2030, growing at a compound annual growth rate (CAGR) of 6.03% during the forecast period. This market is witnessing robust growth, driven by the rising global incidence of breast cancer and the increasing demand for accurate diagnostic and surgical intervention methods.

Breast lesion localization techniques play a critical role in enabling radiologists and surgeons to accurately identify and remove abnormal tissue during breast-conserving surgeries or biopsies. These methods are vital for preserving healthy tissue while ensuring the effective treatment of malignant or suspicious lesions.

One of the principal growth drivers is the heightened awareness of early breast cancer detection, supported by the widespread implementation of screening programs. As breast cancer continues to be one of the most prevalent cancers among women worldwide, early diagnosis is essential to improving survival rates and treatment outcomes. Consequently, there is a growing emphasis on developing advanced and highly reliable localization techniques that enhance surgical precision, minimize the risk of reoperation, and improve overall clinical success.

However, market expansion may be hindered by the high cost of advanced localization technologies and the need for specialized training. These factors pose barriers, particularly in low- and middle-income countries. In addition, regulatory complexities and inconsistent reimbursement frameworks across regions may limit adoption in certain markets.

Key Market Drivers

Expansion of the Global Healthcare Sector

The continued growth of the global healthcare industry is a major catalyst for the breast lesion localization methods market. Global healthcare expenditures now exceed USD 4 trillion annually, with pharmaceuticals and biotechnology accounting for approximately USD 850 billion, and medical technology and diagnostics contributing more than USD 400 billion. With rapid advancements in medical technologies and a stronger focus on early cancer detection, healthcare systems are increasingly investing in sophisticated localization solutions.

These technologies are especially critical for detecting and removing non-palpable breast lesions, ensuring more accurate surgical interventions. The growing incidence of breast cancer is a significant factor supporting this trend. According to the World Health Organization (WHO), breast cancer was responsible for 670,000 deaths globally in 2022. Notably, nearly half of all diagnosed cases occur in women without known risk factors other than age and gender. Additionally, approximately 0.5-1% of breast cancer cases are diagnosed in men.

As healthcare providers enhance screening initiatives and early detection strategies, there is a corresponding increase in the identification of breast lesions requiring pre-surgical localization. Advanced techniques such as wire-guided localization (WGL), radioactive seed localization (RSL), and magnetic seed localization are becoming essential tools in ensuring surgical accuracy and reducing the likelihood of complications or repeat procedures.

Key Market Challenges

Limited Accessibility in Developing Markets

One of the key obstacles facing the breast lesion localization methods market is the restricted availability of advanced technologies in developing regions. While high-income countries have made substantial progress in breast cancer screening and diagnostic infrastructure, many low- and middle-income regions continue to face limited access to modern localization methods.

This disparity impacts the quality of patient care and poses challenges to early diagnosis and effective treatment. Contributing factors include inadequate healthcare infrastructure, limited access to advanced equipment, and a shortage of trained professionals. Many facilities in these regions still rely on traditional methods, such as wire localization, which, while functional, offer lower precision and carry a higher risk of surgical complications and reoperations.

Key Market Trends

Emphasis on Early Detection and Technological Innovation

A prominent trend shaping the breast lesion localization methods market is the increasing prioritization of early breast cancer detection. Digital mammography-recognized for its high specificity and sensitivity (exceeding 90%)-continues to be the cornerstone of breast cancer screening across high-income countries. These efforts are yielding earlier diagnoses and improving survival outcomes.

As global healthcare systems strive to detect cancer at its earliest, most treatable stages, the demand for advanced lesion localization technologies is growing. Early-stage lesions, which are often small and non-palpable, necessitate precise localization to facilitate accurate surgical removal. This requirement is accelerating the adoption of cutting-edge localization techniques, including wire-guided, radioactive seed, and magnetic seed localization.

These technologies are helping redefine breast cancer management by enabling more effective surgical planning, reducing the likelihood of reoperation, and enhancing patient outcomes. As the emphasis on early intervention intensifies, the market is poised to benefit from the increased integration of innovative, image-guided localization methods into clinical workflows.

Key Market Players

• Becton, Dickinson and Company
• SOMATEX Medical Technologies GmbH
• Argon Medical Devices, Inc.
• Merit Medical Systems, Inc.
• Cook Group Incorporated
• STERYLAB S.r.l.
• Theragenics Corporation
• Mdl Srl
• Stryker Corporation

Report Scope

In this report, the Global Breast Lesion Localization Methods Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Lesion Localization Methods Market, By Type:

• Radioisotope Localization
• Radio Guided Occult-Lesion Localization (ROLL)
• Radioactive-Seed Localization (RSL)
• Magnetic Tracer
• Others

Breast Lesion Localization Methods Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Breast Lesion Localization Methods Market.

Available Customizations:

Global Breast Lesion Localization Methods Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Breast Lesion Localization Methods Market

5. Global Breast Lesion Localization Methods Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Radioisotope Localization, Radio Guided Occult-Lesion Localization (ROLL), Radioactive-Seed Localization (RSL), Magnetic Tracer, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Breast Lesion Localization Methods Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Breast Lesion Localization Methods Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Mexico Breast Lesion Localization Methods Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Canada Breast Lesion Localization Methods Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type

7. Europe Breast Lesion Localization Methods Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Breast Lesion Localization Methods Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. Germany Breast Lesion Localization Methods Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Breast Lesion Localization Methods Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Breast Lesion Localization Methods Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Breast Lesion Localization Methods Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Breast Lesion Localization Methods Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Breast Lesion Localization Methods Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Breast Lesion Localization Methods Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. South Korea Breast Lesion Localization Methods Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. Japan Breast Lesion Localization Methods Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Breast Lesion Localization Methods Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. South America Breast Lesion Localization Methods Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Breast Lesion Localization Methods Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. Argentina Breast Lesion Localization Methods Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. Colombia Breast Lesion Localization Methods Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. Middle East and Africa Breast Lesion Localization Methods Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Breast Lesion Localization Methods Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Saudi Arabia Breast Lesion Localization Methods Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. UAE Breast Lesion Localization Methods Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Breast Lesion Localization Methods Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. SOMATEX Medical Technologies GmbH
• 15.3. Argon Medical Devices, Inc.
• 15.4. Merit Medical Systems, Inc.
• 15.5. Cook Group Incorporated
• 15.6. STERYLAB S.r.l.
• 15.7. Theragenics Corporation
• 15.8. Mdl Srl
• 15.9. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer